COMBINATION THERAPY OF NUCANT AND mTOR INHIBITORS FOR TREATING CANCER Application WO-2022223544-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022
Compositions comprising multivalent synthetic ligands of surface nucleolin and… Grant US-9487559-B2 United States of America 08 Nov 2016
HUMAN MONOCLONAL ANTIBODIES TO HUMAN NUCLEOLIN Application EP-3037435-A1 European Patent Office 29 Jun 2016
Human monoclonal antibodies to human nucleolin Grant US-9260517-B2 United States of America 16 Feb 2016
Use of multivalent synthetic ligands of surface nucleolin for treating cancer or… Grant US-9254309-B2 United States of America 09 Feb 2016
HUMAN MONOCLONAL ANTIBODIES TO HUMAN NUCLEOLIN Application EP-2501800-A4 European Patent Office 22 May 2013
HUMAN MONOCLONAL ANTIBODIES TO HUMAN NUCLEOLIN Application EP-2501800-A2 European Patent Office 26 Sep 2012